TY - JOUR
T1 - Factors associated with severity of sleep apnoea syndrome in patients with chronic kidney disease
AU - Tanaka, Akihito
AU - Inaguma, Daijo
AU - Ito, Eri
AU - Kamegai, Naoki
AU - Kato, Akiko
AU - Mizutani, Minami
AU - Shimogushi, Hiroya
AU - Shinjo, Hibiki
AU - Otsuka, Yasuhiro
AU - Takeda, Asami
N1 - Publisher Copyright:
© 2017 Belgian Society of Cardiology.
PY - 2017
Y1 - 2017
N2 - Background In patients with chronic kidney disease (CKD), prevalence of sleep apnoea syndrome (SAS) is reported to be markedly high. However, the factors associated with severity of SAS in such patients rarely have been reported. Methods This was a cross-sectional study of 100 stable non-dialysis patients with CKD who attended a CKD educational programme from April 2014 to August 2015. Diagnosis of SAS and its severity were assessed using a type-3 portable monitor. Results Eighty-six men and 14 women with a mean age of 71.6 ± 9.7 years were included. Mean apnoea-hypopnoea index (AHI) was 26.0 ± 13.8. Severe SAS was seen in 39 patients. Significant differences in brain natriuretic peptide (BNP) level (213.6 ± 329.6 pg/mL vs 107.8 ± 141.3 pg/mL, P < 0.05) and cardiothoracic ratio (CTR, 52.4% ± 6.3% vs 49.6% ± 5.7%, P < 0.05) were seen between patients with and without severe SAS. After adjusting for various parameters, BNP level, CTR, and diameter of the inferior vena cava at the end of inhalation were found to correlate with AHI. Conclusions In patients with CKD, prevalence of severe SAS is extremely high. In these patients, fluid retention, rather than systolic or diastolic function, correlates with severity of SAS.
AB - Background In patients with chronic kidney disease (CKD), prevalence of sleep apnoea syndrome (SAS) is reported to be markedly high. However, the factors associated with severity of SAS in such patients rarely have been reported. Methods This was a cross-sectional study of 100 stable non-dialysis patients with CKD who attended a CKD educational programme from April 2014 to August 2015. Diagnosis of SAS and its severity were assessed using a type-3 portable monitor. Results Eighty-six men and 14 women with a mean age of 71.6 ± 9.7 years were included. Mean apnoea-hypopnoea index (AHI) was 26.0 ± 13.8. Severe SAS was seen in 39 patients. Significant differences in brain natriuretic peptide (BNP) level (213.6 ± 329.6 pg/mL vs 107.8 ± 141.3 pg/mL, P < 0.05) and cardiothoracic ratio (CTR, 52.4% ± 6.3% vs 49.6% ± 5.7%, P < 0.05) were seen between patients with and without severe SAS. After adjusting for various parameters, BNP level, CTR, and diameter of the inferior vena cava at the end of inhalation were found to correlate with AHI. Conclusions In patients with CKD, prevalence of severe SAS is extremely high. In these patients, fluid retention, rather than systolic or diastolic function, correlates with severity of SAS.
UR - http://www.scopus.com/inward/record.url?scp=85028674593&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85028674593&partnerID=8YFLogxK
U2 - 10.1080/00015385.2017.1335048
DO - 10.1080/00015385.2017.1335048
M3 - Article
C2 - 28705074
AN - SCOPUS:85028674593
SN - 0001-5385
VL - 72
SP - 440
EP - 445
JO - Acta Cardiologica
JF - Acta Cardiologica
IS - 4
ER -